AccessibilityHelpAbout Us
Alpha Compute logo

Alpha Compute(NASDAQ) ALP

Market Cap$7.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2013)-100%
5 Year-100%
1 Year-99%
1 Month-41%
$4.76
+2.37%
+0.11Today
After hours$4.67-$0.09 (-1.89%)
Alpha Compute last closing stock price
MetricPriceDate
Last closeUSD 4.562026-09-21
Alpha Compute stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+9.62%USD 4.162026-09-14
1 month-40.97%USD 7.732026-08-21
3 month-68.54%USD 14.502026-06-23
Year to date-84.8%USD 30.002025-12-31
1 year-98.5%USD 303.502025-09-19
3 year-99.81%USD 2,390.002023-09-22
5 year-99.98%USD 20,590.002021-09-22
Since inception-99.99%USD 33,500.002013-06-05

Alpha Compute Financials at a Glance

Market Cap

$7.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$97.00K

Net Income (TTM)

-$43.42M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

1.17 (Average)

Price

$4.76

Volume

49,712.065

Open

$4.75

Previous Close

$4.56

Daily Range

$4.51 - $4.94

52-Week Range

$3.20 - $690.00

Estimated Earnings Date

Nov 25, 2026

ALP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alpha Compute

Portage Biotech Inc. is a biotechnology company focused on the discovery and advancement of innovative pharmaceutical and biotechnological products. The company operates through various subsidiaries and has a diverse pipeline of therapeutic candidates aimed at addressing significant medical needs.

Products and Services
  • IMM60, an activator for iNKT cells
  • INT230-6, currently in Phase I/II trials for solid tumors
  • CellPorter, a platform utilizing cell-permeable peptides
Growth Outlook
  • Strong pipeline with multiple candidates in various stages of development
  • Focus on immuno-oncology and novel therapeutic approaches
  • Potential for partnerships to enhance research and development capabilities
Financial Highlights
  • Recent quarterly net income of -$1,875,500, reflecting ongoing R&D investments
  • Cash and cash equivalents of $1,670,000 as of March 31, 2025
  • Trailing twelve months (TTM) revenue of $0, indicating early-stage development
Portage Biotech Inc. is dedicated to advancing its innovative therapies, particularly in the fields of immuno-oncology and targeted treatments. The company’s diverse product pipeline includes several promising candidates, such as IMM60 and INT230-6, which are designed to address critical health challenges. Despite reporting a net loss in recent quarters, the focus on research and development positions the company for potential future growth. The current cash reserves provide a foundation for continued investment in its therapeutic programs. As the biotechnology sector evolves, Portage Biotech's strategic initiatives may attract interest from investors looking for opportunities in innovative healthcare solutions.
AI Generated • Sep 19, 2026

Industry

Biotechnology

Sector

Health Care

Employees

2

CEO

Brittany Kaiser

Website

www.portagebiotech.com

Headquarters

Dover, DE 19901, US

ALP Financials

Key Financial Metrics (TTM)

Gross Margin

100.00%

Operating Margin

-25275.26%

Net Income Margin

-44767.01%

Return on Equity

-748.11%

Return on Capital

-313.51%

Return on Assets

-222.35%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.55M

Volume

49.71K

Avg. Volume

125.82K

Financials (TTM)

Gross Profit

$97.00K

Operating Income

-$24.52M

EBITDA

-$32.82M

Operating Cash Flow

-$31.54M

Capital Expenditure

-$6.21M

Free Cash Flow

-$37.75M

Cash & ST Invst.

$1.80M

Total Debt

$138.00K

Alpha Compute Performance Analysis

Alpha Compute annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31USD 0N/A
20242024-03-31USD 0N/A
20252025-03-31USD 0N/A
20262026-03-31USD 97,000N/A
Alpha Compute sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-30N/A
Q22025-09-30N/A
Q32025-12-31N/A
Q42026-03-31N/A
Alpha Compute annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31USD -6,489.92402.4%
20242024-03-31USD -3,894.90-40.0%
20252025-03-31USD -286.01-92.7%
20262026-03-31USD -208.83-27.0%
Alpha Compute sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-30-1411.8%
Q22025-09-30-60.7%
Q32025-12-3179.7%
Q42026-03-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

$48.50K

N/A

Gross Profit

$48.50K

N/A

Gross Margin

100.00%

N/A

Market Cap

$7.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$327.58K

N/A

Employees

22

N/A

Net Income

-$13.74M

-632.7%

EBITDA

-$8.44M

-474.4%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

$1.80M

+7.7%

Total Debt

$138.00K

N/A

Accounts Receivable

$21.00K

+75.0%

Inventory

$0.00

N/A

Long Term Debt

$73.00K

N/A

Short Term Debt

$65.00K

N/A

Return on Assets

-2.22%

N/A

Return on Invested Capital

-3.61%

N/A

Free Cash Flow

-$21.59M

-1848.4%

Operating Cash Flow

-$20.55M

-1754.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NCPLNetcapital Inc.
$1.01+36.36%
AMTDAMTD IDEA Group
$0.71-3.18%
MEGLMagic Empire Global Limited
$1.14+0.88%
OXBROxbridge Re Holdings Limited
$1.41-4.73%

Trending Stocks

Symbol / CompanyPricePrice Chg
WBDWarner Bros. Discovery
$30.80+10.79%
GRMLGreenland Mines
$9.42+230.53%
INTCIntel
$121.78+12.14%
NVDANvidia
$227.38+2.30%

Questions About ALP

What is the current price of Alpha Compute?

Alpha Compute is trading at $4.56 per share.

What is the 52-week range for Alpha Compute?

Over the past 52 weeks, Alpha Compute has traded between $3.20 and $690.00.

How much debt does Alpha Compute have?

As of the most recent reporting period, Alpha Compute reported total debt of $0.00.

How much cash does Alpha Compute have on hand?

Alpha Compute reported $183.00K in cash and cash equivalents in its most recent financial results.

What is Alpha Compute’s dividend yield?

Alpha Compute does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services